China's high-speed validity trials can be hard to keep up with
CNIPA boasts of "world-leading" time to decision, while some users see a "mad scramble"
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.